Which venture capital firms are delivering the best returns in the dynamic biotech industry?

This STAT Report, now in its fifth year, offers an exclusive, data-driven analysis of the top-performing venture capital firms.

In this comprehensive report, STAT News’ Allison DeAngelis dives into the financial performance and strategic decisions of over a dozen leading biotech venture capital firms, including new names joining this year’s list.

With a wealth of new data from 2023, uncover the latest trends and moves in biotech investment. Whether you’re an investor, industry professional, or simply interested in the financial dynamics of biotech, this 2024 STAT Report ranking VC companies is your essential guide to understanding the forces driving success in this high-stakes sector.

What’s Inside the STAT Report?

• A detailed ranking of biotech venture capital firms based on their returns
• Exclusive analysis by STAT News’ Allison DeAngelis on the financial strategies and successes of top firms
• Key trends and new entrants in the biotech investment landscape

For information on licensing this report for external distribution or marketing, please visit our partners at PARS here. Please also refer to the Terms and Conditions for additional information on use.

Review the 2023 edition of this report here.